SCHEMBL5759548

SCHEMBL5759548

C[C@@H](NC(c1ccccc1)S(=O)(=O)c1ccc2nc(SCC3CCCCC3)sc2c1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 2/20 0.42
HSP90AA1 P07900 1/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
MAPT P10636 4/20 0.39
RAB9A P51151 1/20 0.39
CLK1 P49759 1/20 0.39
CTSK P43235 2/20 0.38
TP53 P04637 2/20 0.38
MAOB P27338 1/20 0.37
CTSL P07711 1/20 0.37
CNR1 P21554 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CCR3 P51677 1/20 0.36
MAPK1 P28482 1/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
CYP2C9 P11712 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5753490 0.94 LMNA (0.41) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5760236 0.88 ALDH1A1 (0.39) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL27586676 0.84 ALDH1A1 (0.39) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5757798 0.84 LMNA (0.52) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5757831 0.79 SMN1; SMN2 (0.51) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL28747860 0.79 ALDH1A1 (0.38) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5755212 0.78 ALDH1A1 (0.51) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5754374 0.78 ALDH1A1 (0.45) ALDH1A1LMNAMAPTRAB9ACTSK
SCHEMBL5755972 0.77 POLB (0.48) ALDH1A1LMNATSHRHSP90AA1HPGD
SCHEMBL5759539 0.77 PLAU (0.41) ALDH1A1LMNATSHRHSP90AA1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1208092-B1 SULFONAMIDE DERIVATIVE AS A MATRIX METALLOPROTEINASE INHIBITOR SAMSUNG ELECTRONICS CO LTD (KR) 2006-06-21 EP disclosed
US-6548667-B2 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase SAMSUNG ELECTRONICS CO. LTD. (KR) 2003-04-15 US disclosed
US-20020169314-A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor SAMSUNG ELECTRONICS CO. LTD. (KR) 2002-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169314-A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor MMP9, MMP3, MMP14 ALDH1A1 311/4885LMNA 1839/4885TSHR 4446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.